Intervention Study to Assess the Effects of Moderate and High Intensity Aerobic Training on Physical Capacity and Activity Level in Persons With Incomplete Spinal Cord Injury
NCT ID: NCT01903226
Last Updated: 2018-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2013-01-31
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spinal Cord Injury: Endurance, Strength and Cardiac Function Induced by Efficient Training Protocols
NCT00987155
Performance Developement of Patients With Paraplegia During First Rehabilitation
NCT03405558
Resistance Training to Improve Strength and Functional Trunk Stability in Adults With Paraplegia
NCT03949699
High Intensity Exercise in Incomplete SCI
NCT03714997
Cardiorespiratory Fitness Training in Patients with Incomplete Spinal Cord Injury
NCT06259227
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Randomized controlled trial.
Participants:
45 subjects, between 18 and 65 years of age, will be recruited with the following inclusion criteria: Traumatic spinal cord injury, incomplete lesions (classified as ASIA D), admitted to Sunnaas Rehabilitation Hospital for primary rehabilitation, and able to walk for 5 minutes on the treadmill (without assistive aids) at 4 km/hour.
Subjects with cardiovascular diseases, progressive diseases and severe psychiatric conditions will be excluded.
Procedures:
The participants will be included after medical approval (by a specialist in physical medicine and rehabilitation) and before being discharged from primary rehabilitation. During the last week at the hospital, usually between 3 to 6 months post injury, a pre-test to examine physical capacity will be performed; maximal exercise test on a treadmill and six-minute walking test (Fig. 1).
After the pre-test the participants will be randomized into one of three groups; Intervention Group I (high intensity training), Intervention Group II (medium intensity training), and a Control Group (treatment as usual, no additional training). To achieve balanced randomization (the compared groups should have about the same size), we will use block randomization. A computer random number generator will be used, with a block size of 15 and an allocation ratio of 1:1.
The subjects in the training groups will have practical training at the hospital in how to perform moderate or high intensity training. They will be taught how to apply a heart rate monitor and how to use it during training sessions.
At discharge from primary rehabilitation, and before start-up of the 12 week training program, the physical activity level (energy expenditure; kilo joule (kJ) · min -1) will be monitored by wearing a SWA for seven days in the home situation.
After having completed the training program, the participants (including those in the control group) will wear the SWA in 7 days and return to Sunnaas Rehabilitation Hospital to repeat the physical capacity tests (post-test). This procedure will also be repeated at a follow-up one year after discharge from primary rehabilitation (12-months follow-up).
All tests are performed under supervision of a physiotherapist, who has several years of experience in exercise testing. This physiotherapist is unaware of which of the three groups the patient the patient is recruited from (blind controlled trail).
Interventions:
Subjects in the two intervention groups will perform a 12 week individual training program, where 15 subjects will perform high intensity training and 15 subjects will perform a training program with moderate intensity training. Since literature indicates that SCI patients, on group level, do not improve their physical capacity after being discharged, our subjects will perform the training program in their home situation. To verify the intensity level during the training session, the participants have to wear a heart rate monitor. The heart rate will be stored for later analyses. Subjects in both training groups will be contacted, by telephone, during the first and the sixth week of the training program, to evaluate the training. A training log will be filled out by all the subjects (including those in the control group) during week 2-13.
When comparing two training programs, one must be sure that the total amount of energy expended (total oxygen uptake) is equal. The calculation of the total oxygen uptake for the different training programs is based on the relationship between %HRmax and %VO2max, established by the American College of Sports Medicine (ACSM).
Intervention group I - High intensity training The training program with high intensity will consist of two high intensity training sessions per week, using a treadmill or by outdoor walking/running. During these sessions the subjects will walk/run 4 times 4 minutes at an intensity of 85-95% of HRmax (interval training). Between the intervals, the subjects will have an active resting period (3 minutes), in which they walk at an intensity of 70% of HRmax. The subjects are free to choose which days of the week they conduct the training sessions, however, they must have at least one (resting) day in between.
Intervention group II - Moderate intensity training The training program with moderate intensity will consist of three moderate intensity training sessions per week, using a treadmill or by walking outdoor. During these sessions the subjects will walk for 45 minutes at 70% of HRmax. The subjects are free to choose which days of the week they conduct their training session Control group The subjects in the control group (n=15) will have no additional training program, but left with treatment as usual. They will, however, be offered an individual training program after the one year follow-up test.
Outcome measures
Primary outcome measures:
\- Difference in VO2peak (change between pre-test and post-test 1) for both interventions groups and the control group.
Healthy, untrained subjects show about 0.5 % increase in VO2peak for every (high intensity) training session. Assuming that persons with incomplete SCI show the same increase, we need about 15 subjects to detect a mean difference of 12 % in VO2peak. Sample size calculation is based on a standard deviation of 10 % with a significance level of 0.05 and power output of 80%.
Secondary outcome measures:
* Difference in VO2peak between intervention group 1 (high intensity) and 2 (moderate intensity), after having completed the training program (post-test 1)
* Changes in VO2peak (changes between pre-test, post-test 1 and post-test 2) for both interventions groups and the control group.
* Difference in VO2peak between intervention group I (high intensity) and II (moderate intensity), one year after discharge (post-test 2).
* Difference in daily energy expenditure (kilo joule (kJ) · min -1) between pre-test, posttest 1 and post-test 2
* Difference in daily energy expenditure (kilo joule (kJ) · min -1) between intervention group I (high intensity) and II (moderate intensity), one year after discharge (post-test 2).
Data analyses and statistics:
Oxygen uptake during the last 30 seconds of the maximal exercise test will be used to estimate peak oxygen uptake (VO2peak). VO2peak of pre- and post test (1, 2 and 3) will be compared to evaluate a possible training effect. From the SWA data, the daily energy expenditure (energy expended during one week divided by 7 days) before the training program, after the training program and one year after discharge, will be compared to evaluate a possible effect of the training programs on the subjects' physical activity level.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High intensity training
Patients in this group will perform high aerobic intensity training, in 30 minutes, twice a week, in a 12 week period.
High intensity training
Moderate intensity training
Patients in this group will perform moderate aerobic intensity training, in 45 minutes, three times a week, in a 12 week period.
Moderate intensity training
controll
Patients in this group will perform no (additional) training.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High intensity training
Moderate intensity training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* incomplete lesion (classified as ASIA D)
* admitted to Sunnaas Rehabilitation Hospital for primary rehabilitation,
* able to walk for 5 minutes on the treadmill (without assistive aids) at 4 km/hour
Exclusion Criteria
* progressive diseases
* severe psychiatric conditions
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sunnaas Rehabilitation Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matthijs Ferdinand Wouda
PhD candidate
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sunnaas Rehabilitation Hospital
Nesoddtangen, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SPREK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.